NVP-HDM201: cellular and in vivo profile of a novel highly potent and selective PPI inhibitor of p53 Mdm2

被引：5
|
作者：
Jeay, Sebastien
Chene, Patrick
Ferretti, Stephane
Furet, Pascal
Gruenenfelder, Bjoern
Guagnano, Vito
Guerreiro, Nelson
Halilovic, Ensar
Hofmann, Francesco
Kellen, Joerg
Leonard, Michelle
Mah, Robert
Masuya, Keiichi
Ramos, Rita
Rynn, Caroline
Ruetz, Stephan
Stachyra-Valat, Therese
Stutz, Stefan
Vaupel, Andrea
Wuerthner, Jens
Holzer, Philipp
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1225
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1225
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Activation of p53 by the MDM2 inhibitor RG7112 impairs thrombopoiesis
    Iancu-Rubin, Camelia
    Mosoyan, Goar
    Glenn, Kelli
    Gordon, Ronald E.
    Nichols, Gwen L.
    Hoffman, Ronald
    [J]. EXPERIMENTAL HEMATOLOGY, 2014, 42 (02) : 137 - 145
  • [42] Identification of a new p53/MDM2 inhibitor motif inspired by studies of chlorofusin
    Cominetti, Marco M. D.
    Goffin, Sarah A.
    Raffel, Ewan
    Turner, Kerrie D.
    Ramoutar, Jordann C.
    O'Connell, Maria A.
    Howell, Lesley A.
    Searcey, Mark
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (21) : 4878 - 4880
  • [43] Arsenic disrupts cellular levels of p53 and mdm2: A potential mechanism of carcinogenesis
    Hamadeh, HK
    Vargas, M
    Lee, E
    Menzel, DB
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (02) : 446 - 449
  • [44] In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
    Vassilev, LT
    Vu, BT
    Graves, B
    Carvajal, D
    Podlaski, F
    Filipovic, Z
    Kong, N
    Kammlott, U
    Lukacs, C
    Klein, C
    Fotouhi, N
    Liu, EA
    [J]. SCIENCE, 2004, 303 (5659) : 844 - 848
  • [45] Inactivation of Mdm2 restores apoptosis proficiency of cooperativity mutant p53 in vivo
    Klimovich, Boris
    Stiewe, Thorsten
    Timofeev, Oleg
    [J]. CELL CYCLE, 2020, 19 (01) : 109 - 123
  • [46] Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo
    Ringshausen, Ingo
    O'Shea, Cloclagh C.
    Finch, Andrew J.
    Swigart, Lamorna Brown
    Evan, Gerard I.
    [J]. CANCER CELL, 2006, 10 (06) : 501 - 514
  • [47] The Mdm2/p53 Pathway Preserves Normal Adult Heart Function, in vivo
    Billia, Filio
    Hauck, Ludger
    Grothe, Daniela
    Mak, Tak W.
    [J]. CIRCULATION, 2013, 128 (22)
  • [48] Reactivation of p53 signaling in hepatoblastoma with a stapled peptide dual inhibitor of MDM2 and MDM4
    Woodfield, Sarah E.
    Patel, Roma H.
    Ibarra, Aryana M.
    Chen, Zhenghu
    Vasudevan, Sanjeev A.
    [J]. CANCER RESEARCH, 2018, 78 (19)
  • [49] Potent D-peptide antagonists of MDM2 as a novel class of p53 activators for potential anticancer therapy
    Zhan, C.
    Zhao, L.
    Wu, X.
    Yuan, W.
    Pazgier, M.
    Lu, W.
    [J]. BIOPOLYMERS, 2011, 96 (04) : 464 - 464
  • [50] FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53
    Ochocka, Anna Maria
    Kampanis, Petros
    Nicol, Samantha
    Allende-Vega, Nerea
    Cox, Miranda
    Marcar, Lynnette
    Milne, Diane
    Fuller-Pace, Frances
    Meek, David
    [J]. FEBS LETTERS, 2009, 583 (04): : 621 - 626
12345